CIBINQO

Indicated For

atopic dermatitis

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get CIBINQO (abrocitinib) at Low or No Cost CIBINQO (abrocitinib) is a prescription medication used to treat moderate to severe atopic dermatitis (eczema) in adults and children 12 years and older whose condition has not been controlled with other systemic treatments. The **Pfizer Patient Assistance Program** offers **free CIBINQO** to eligible uninsured or underinsured patients who meet specific financial and residency criteria, helping those who cannot afford their medication[1][3][5]. This guide explains everything you need to know about qualifying for and applying to the program in simple terms. It's designed for patients like you—whether you're newly diagnosed or struggling with ongoing treatment costs. ## About CIBINQO (abrocitinib) **CIBINQO** is an oral tablet taken once daily that works by blocking Janus kinase 1 (JAK1), a protein involved in the inflammation causing eczema flare-ups. It's approved for patients whose eczema covers a significant portion of their body and hasn't responded well to topical treatments or other therapies[2][8]. Common side effects include upper respiratory infections, headache, acne, and herpes simplex infections; serious risks include infections, blood clots, and cancer—discuss these with your doctor. Unlike creams or injections, CIBINQO is a pill, making it convenient for long-term management. However, its list price can exceed $5,000 per month without assistance, which is why programs like Pfizer's exist[6]. ## Who Qualifies for the Pfizer Patient Assistance Program? The program is for **uninsured or underinsured patients** who live in the US (including Puerto Rico and US Virgin Islands) and are treated in an outpatient setting. You must have a valid prescription from a licensed US healthcare provider[3][5]. Key requirements: - **No commercial insurance**: Patients with job-based or employer-sponsored insurance do not qualify[5]. - **Medicare patients**: May qualify if they can't afford copays, are in the coverage gap (donut hole), or the drug isn't covered—but no claims can be submitted to Medicare[3][5]. - **Residency**: US address required (no proof of citizenship needed)[5]. - **Financial need**: Proof of income is required; eligibility is based on inability to pay, though specific income limits aren't publicly detailed—contact the program for your situation[1][5]. - **Outpatient care only**: Not for hospital or inpatient use[3]. **Important**: This is not health insurance. Pfizer can change or end the program anytime[3]. Additional criteria may apply[3]. ## Income Eligibility Breakdown The Pfizer Patient Assistance Program doesn't publish fixed Federal Poverty Level (FPL) percentages or household size thresholds online. Instead, eligibility focuses on proving you **cannot afford your medication**, with required proof of income[1][5]. Patients appearing eligible for Medicaid may need to apply there first for some drugs[5]. Here's a general guide based on program details: | Household Size | Typical Income Consideration | Notes | |---------------|------------------------------|-------| | Individual | Proof required; no fixed limit published | Uninsured/underinsured only[5] | | Couple | Proof required; no fixed limit published | Household income assessed[1] | | Family of 3 | Proof required; no fixed limit published | Includes dependents[5] | | Family of 4+ | Proof required; no fixed limit published | Contact for details[3] | **Tip**: Call (833) 956-3376 or 1-844-989-PATH (7284) to check your eligibility before applying. Provide recent income docs like W-2, pay stubs, or tax returns[1][5]. ## Insurance Requirements - **Uninsured patients**: Fully eligible if other criteria met[3]. - **Underinsured**: Qualify if insurance doesn't cover CIBINQO enough (e.g., high copays, denials). Medicare patients with affordability issues may apply, but **no reimbursement claims to insurers or Medicare allowed**[3][5]. - **Commercial insurance**: Not eligible for this free program—consider Pfizer Dermatology Patient Access™ for copay help or Interim Care Rx (free supply during delays, up to 2 years for eligible commercially insured)[2][6]. ## Step-by-Step Application Process The program offers **multiple application methods** for flexibility[1]. 1. **Check eligibility**: Visit www.PfizerRxPathways.com, enter "CIBINQO," and use the Program Finder. Or call (833) 956-3376 / 1-844-989-PATH (7284)[1][5]. 2. **Gather documents**: - **Proof of income** (W-2, pay stub, tax return)[1][5]. - **Proof of residency** (utility bill, etc.)[program details]. - **Prescription** from your doctor[1]. - Healthcare provider signature on enrollment form[2]. 3. **Complete application**: - **Online**: Use Pfizer PAP Connect at PfizerRxPathways.com for CIBINQO (fastest)[1]. - **Download & fax/mail**: Get combined HCP/Patient form from Pfizer Dermatology Patient Access site, complete with doctor, and fax/mail[2][6]. - **Phone help**: Counselors guide you[5]. 4. **Submit**: Fax, mail, or online. Your doctor can e-prescribe to Sonexus Health (NCPDP: 5910206)[2]. 5. **Wait for approval**: 2-3 weeks; you'll be notified[1]. ## Timeline and Delivery - **Processing**: 2-3 weeks after submission[1]. - **Delivery**: If approved, **CIBINQO ships free directly to your home** (or pharmacy in some cases)[program details][2]. - **Supply duration**: Typically 1-3 months per approval; **reauthorization required** annually or as needed[program details][6]. ## Alternatives if Denied - **Pfizer Dermatology Patient Access™**: Copay cards, vouchers (30-day trial for new patients), prior auth help, Interim Care Rx (free during insurance delays)[2][6][7]. - **State programs/Medicaid**: Apply if eligible[5]. - **Other PAPs**: Check NeedyMeds.org or RxAssist.org. - **Samples/Vouchers**: Ask your doctor for CIBINQO samples or new-patient voucher[2][7]. - **Generic/biosimilars**: None available for CIBINQO[program details]. - **Reapply**: Fix issues (e.g., more income proof) and resubmit[1]. ## Reauthorization and Refills **Reauthorization is required**. When your supply runs low (e.g., 2 weeks left), reapply via the same process or Pfizer Dermatology Patient Access Patient Portal. Your doctor must confirm ongoing need[program details][6]. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility rules change; **always verify with Pfizer at (833) 956-3376 or PfizerRxPathways.com** [1][3]. Not medical advice—consult your healthcare provider. Pfizer reserves rights to modify/discontinue the program without notice. No guarantee of approval[3]. Word count: 1028.

Program information last verified: March 25, 2026